levofloxacin has been researched along with azd0914 in 2 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (azd0914) | Trials (azd0914) | Recent Studies (post-2010) (azd0914) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 33 | 8 | 33 |
| Protein | Taxonomy | levofloxacin (IC50) | azd0914 (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Staphylococcus aureus | 4.3 | |
| DNA gyrase subunit A | Staphylococcus aureus | 4.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammerschlag, MR; Huband, MD; Kohlhoff, SA | 1 |
| Crabb, DM; Duffy, LB; Huband, MD; Waites, KB | 1 |
2 other study(ies) available for levofloxacin and azd0914
| Article | Year |
|---|---|
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Chlamydia trachomatis; Chlamydophila pneumoniae; DNA Gyrase; Doxycycline; Isoxazoles; Levofloxacin; Microbial Sensitivity Tests; Morpholines; Oxazolidinones; Spiro Compounds; Topoisomerase II Inhibitors | 2014 |
In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Doxycycline; Humans; Isoxazoles; Levofloxacin; Microbial Sensitivity Tests; Morpholines; Mycoplasma; Mycoplasma genitalium; Mycoplasma pneumoniae; Oxazolidinones; Spiro Compounds; Ureaplasma | 2015 |